ArticleRheumatology (Oxford, England)2024

Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.

Hermine I Brunner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.